MindRank AI
MindRank is an AI-powered drug discovery company that integrates machine learning, biology, and chemistry to innovate in drug development. Their proprietary drug MDR-001, an oral small-molecule GLP-1 RA, received US IND approval in just 19 months, targeting obesity and type 2 diabetes. With a focus on hard-to-drug molecular targets, MindRank collaborates with biopharma to deliver advanced drug candidates, including an allosteric inhibitor with Best-in-Class potential. The company boasts a team of over 40 scientists, recognized for their expertise and contributions to AI-driven drug discovery, and has received accolades such as being named one of Forbes Asia's "100 to Watch" in 2023.
MindRank AI
MindRank is an AI-powered drug discovery company that integrates machine learning, biology, and chemistry to innovate in drug development. Their proprietary drug MDR-001, an oral small-molecule GLP-1 RA, received US IND approval in just 19 months, targeting obesity and type 2 diabetes. With a focus on hard-to-drug molecular targets, MindRank collaborates with biopharma to deliver advanced drug candidates, including an allosteric inhibitor with Best-in-Class potential. The company boasts a team of over 40 scientists, recognized for their expertise and contributions to AI-driven drug discovery, and has received accolades such as being named one of Forbes Asia's "100 to Watch" in 2023.